Lymphocyte subsets | ALS-nci (49 patients) | ALS-ci (32 patients) | P value |
---|---|---|---|
Total T (#) | 1247.00 [962.50–1375.00] | 996.50 [785.50–1149.50] | 0.005 |
CD4+ T (#) | 767.63 ± 224.23 | 652.47 ± 190.75 | 0.019 |
CD8+ T (#) | 360.00 [277.00–466.00] | 262.00 [210.00–432.50] | 0.019 |
B (#) | 219.00 [144.00–297.50] | 158.50 [136.25–213.00] | 0.035 |
NK (#) | 179.00 [132.00–284.50] | 194.00 [115.50–376.75] | 0.896 |
Total T (%) | 73.36 [68.06–76.55] | 68.97 [63.80–78.74] | 0.284 |
CD4+ T (%) | 45.75 ± 7.94 | 44.79 ± 8.06 | 0.598 |
CD8+ T (%) | 22.75 ± 6.24 | 21.03 ± 7.92 | 0.309 |
B (%) | 13.60 ± 4.76 | 12.89 ± 4.97 | 0.519 |
NK (%) | 11.51 [9.32–18.54] | 13.96 [8.91–20.74] | 0.356 |
CD4+/CD8+ ratio | 2.01 [1.59–2.73] | 2.15 [1.69–3.47] | 0.484 |